The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient experience with breast cancer care delivered in a multidisciplinary clinic.
 
Stephanie L. Graff
Stock and Other Ownership Interests - HCA Healthcare
Honoraria - Publicis Health
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; Genentech; Novartis; Novartis (Inst); Pfizer; Seagen (Inst)
Speakers' Bureau - OncLive
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Dana Farber Cancer Hospital (Inst); Eisai (Inst); Foundation Medicine (Inst); Genentech (Inst); GRAIL (Inst); H3 Biomedicine (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Lilly (Inst); Merck (Inst); Merus NV (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Polyphor (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); TapImmune Inc. (Inst)
 
Julie Principe
No Relationships to Disclose
 
Mary Anne Anne Fenton
Employment - Astellas Pharma (I)
 
Rochelle Strenger
No Relationships to Disclose
 
Don S. Dizon
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; i-Mab; Oasmia Pharmaceutical AB; Pfizer; Regeneron; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Kazia Therapeutics (Inst); Pfizer (Inst)
 
Megan H. Begnoche
No Relationships to Disclose
 
Anne-Marie Galvin
No Relationships to Disclose